Vaso Corp Stock Other OTC
Equities
US9223211049
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
04-01 | Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-01 | Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2022 | 80.02M 109M | Sales 2023 | 81.02M 111M | Capitalization | 53.47M 73.06M |
---|---|---|---|---|---|
Net income 2022 | 11M 15.03M | Net income 2023 | 4M 5.47M | EV / Sales 2022 | 0.13 x |
Net cash position 2022 | 18.52M 25.3M | Net cash position 2023 | 23.26M 31.78M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
2.41
x | P/E ratio 2023 |
11.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.4% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Ma
CEO | Chief Executive Officer | 60 | 07-05-31 |
Jonathan Newton
DFI | Director of Finance/CFO | 63 | 10-08-31 |
Michael Beecher
DFI | Director of Finance/CFO | 79 | 11-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Castle
COO | Chief Operating Officer | 55 | 10-08-18 |
Jun Ma
CEO | Chief Executive Officer | 60 | 07-05-31 |
David Lieberman
BRD | Director/Board Member | 79 | 11-02-27 |
1st Jan change | Capi. | |
---|---|---|
+8.37% | 219B | |
+6.37% | 183B | |
+10.64% | 133B | |
+24.86% | 108B | |
+0.27% | 63.06B | |
+12.01% | 52.02B | |
+3.96% | 48.2B | |
-0.04% | 40.37B | |
+14.67% | 39.35B |